Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 1 1 2019
pubmed: 1 1 2019
medline: 18 12 2019
Statut: ppublish

Résumé

To investigate a Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak event involving multiple healthcare facilities in Riyadh, Saudi Arabia; to characterize transmission; and to explore infection control implications. Outbreak investigation. Cases presented in 4 healthcare facilities in Riyadh, Saudi Arabia: a tertiary-care hospital, a specialty pulmonary hospital, an outpatient clinic, and an outpatient dialysis unit. Contact tracing and testing were performed following reports of cases at 2 hospitals. Laboratory results were confirmed by real-time reverse transcription polymerase chain reaction (rRT-PCR) and/or genome sequencing. We assessed exposures and determined seropositivity among available healthcare personnel (HCP) cases and HCP contacts of cases. In total, 48 cases were identified, involving patients, HCP, and family members across 2 hospitals, an outpatient clinic, and a dialysis clinic. At each hospital, transmission was linked to a unique index case. Moreover, 4 cases were associated with superspreading events (any interaction where a case patient transmitted to ≥5 subsequent case patients). All 4 of these patients were severely ill, were initially not recognized as MERS-CoV cases, and subsequently died. Genomic sequences clustered separately, suggesting 2 distinct outbreaks. Overall, 4 (24%) of 17 HCP cases and 3 (3%) of 114 HCP contacts of cases were seropositive. We describe 2 distinct healthcare-associated outbreaks, each initiated by a unique index case and characterized by multiple superspreading events. Delays in recognition and in subsequent implementation of control measures contributed to secondary transmission. Prompt contact tracing, repeated testing, HCP furloughing, and implementation of recommended transmission-based precautions for suspected cases ultimately halted transmission.

Identifiants

pubmed: 30595141
pii: S0899823X18002908
doi: 10.1017/ice.2018.290
pmc: PMC7108661
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-88

Références

Emerg Infect Dis. 2016 Jan;22(1):32-40
pubmed: 26692003
Emerg Infect Dis. 2016 Jun;22(6):
pubmed: 27192543
Infect Control Hosp Epidemiol. 2016 Oct;37(10):1147-55
pubmed: 27426423
Ann Intern Med. 2016 Jul 19;165(2):87-93
pubmed: 27272273
Euro Surveill. 2015 Jun 25;20(25):7-13
pubmed: 26132767
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Clin Infect Dis. 2016 Feb 15;62(4):477-483
pubmed: 26565003
Clin Infect Dis. 2017 Aug 15;65(4):675-679
pubmed: 28575307
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Clin Microbiol. 2014 Jan;52(1):67-75
pubmed: 24153118
N Engl J Med. 2013 Aug 1;369(5):407-16
pubmed: 23782161
mBio. 2015 Sep 08;6(5):e01280-15
pubmed: 26350969
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Clin Infect Dis. 2016 Dec 10;64(5):551-557
pubmed: 27940937
N Engl J Med. 2017 Feb 9;376(6):584-594
pubmed: 28177862
Emerg Microbes Infect. 2017 Nov 8;6(11):e101
pubmed: 29116217
Clin Microbiol Infect. 2016 Oct;22(10):880-886
pubmed: 27475739
Open Forum Infect Dis. 2018 Apr 28;5(5):ofy095
pubmed: 30294616
N Engl J Med. 2015 Feb 26;372(9):846-54
pubmed: 25714162
J Med Virol. 2018 Feb;90(2):367-371
pubmed: 28906003
Euro Surveill. 2012 Dec 06;17(49):
pubmed: 23231891
Emerg Infect Dis. 2015 Dec;21(12):2186-9
pubmed: 26583829
Am J Infect Control. 2018 Sep;46(9):1022-1025
pubmed: 29661625
Clin Infect Dis. 2016 Mar 15;62(6):755-60
pubmed: 26679623

Auteurs

Khalid H Alanazi (KH)

1Ministry of Health,Riyadh,Saudi Arabia.

Marie E Killerby (ME)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Holly M Biggs (HM)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Glen R Abedi (GR)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Hani Jokhdar (H)

1Ministry of Health,Riyadh,Saudi Arabia.

Ali A Alsharef (AA)

1Ministry of Health,Riyadh,Saudi Arabia.

Mutaz Mohammed (M)

1Ministry of Health,Riyadh,Saudi Arabia.

Osman Abdalla (O)

1Ministry of Health,Riyadh,Saudi Arabia.

Aref Almari (A)

1Ministry of Health,Riyadh,Saudi Arabia.

Samar Bereagesh (S)

1Ministry of Health,Riyadh,Saudi Arabia.

Sameh Tawfik (S)

1Ministry of Health,Riyadh,Saudi Arabia.

Husain Alresheedi (H)

1Ministry of Health,Riyadh,Saudi Arabia.

Raafat F Alhakeem (RF)

1Ministry of Health,Riyadh,Saudi Arabia.

Ahmed Hakawi (A)

1Ministry of Health,Riyadh,Saudi Arabia.

Haitham Alfalah (H)

3King Saud Medical City,Riyadh,Saudi Arabia.

Hala Amer (H)

3King Saud Medical City,Riyadh,Saudi Arabia.

Natalie J Thornburg (NJ)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Azaibi Tamin (A)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Suvang Trivedi (S)

5IHRC,contractor to National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Suxiang Tong (S)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Xiaoyan Lu (X)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Krista Queen (K)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Yan Li (Y)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Senthilkumar K Sakthivel (SK)

6Batelle, contractor to National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA,USA.

Ying Tao (Y)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Jing Zhang (J)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Clinton R Paden (CR)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Hail M Al-Abdely (HM)

1Ministry of Health,Riyadh,Saudi Arabia.

Abdullah M Assiri (AM)

1Ministry of Health,Riyadh,Saudi Arabia.

Susan I Gerber (SI)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

John T Watson (JT)

2Division of Viral Diseases,National Center for Immunization and Respiratory Diseases,Centers for Disease Control and Prevention,Atlanta,Georgia,United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH